Filing Details
- Accession Number:
- 0000899243-16-029762
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-22 17:39:49
- Reporting Period:
- 2016-09-22
- Filing Date:
- 2016-09-22
- Accepted Time:
- 2016-09-22 17:39:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1462948 | Anders Frank Wilson | 940 Winter Street Waltham MA 02451 | Please See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-09-22 | 46,611 | $21.01 | 108,795 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-09-22 | 46,611 | $55.00 | 62,185 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | NQ Stock Option(right to buy) | Disposition | 2016-09-22 | 46,611 | $0.00 | 46,611 | $21.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-02-09 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on February 17, 2016 and modified August 11, 2016.
- The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account.
- This option became exercisable in three equal annual installments beginning on February 9, 2011, which was the first anniversary of the date on which the option was granted.